References
- Aitken J. M., Hart McKay D., Smith D. A. The effect of long-term mestranol administration on calcium and phosphorus homeostasis in oophorectomized women. Clin Sci 1979; 31: 233
- Antures C. M. F., Stolley P. D., Rosenshein N. B., Davies J. L., Tonascia J. A., Brown C, Burnett L., Rutledge A., Pokempner M., Garcia R. Endomet-rial cancer and estrogen use. N Engl J Med 1979; 300: 9
- Bush T. L., Xowan L. D., Barrett-Connor E., Cri-Qul M. H., Karon J. M., Wallace R. B., Tyroler H. A., Rifkind B. M. Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics. Program follow-up study. Jama 1983; 249: 903
- Davis M. E., Lanzl L. H., Cox A. B. Detection, prevention and retardation of menopausal osteoporosis. Obstet Gynecol 1970; 36: 187
- Gallagher J. C., Nordin B. E.C. Oestrogens and calcium metabolism. Fron Horm Res 1973; 2: 98
- Gallagher J. C., Nordin B. E.C. Effects of oestrogen and progestogen therapy on calcium metabolism in post-menopausal women. Front Horm Res 1975; 3: 150
- Gray L. A., Christopherson W. M., Hoover R. N. Estrogens and endometrial carcinoma. Obstet Gynecol 1977; 49: 385
- Horwitz R. I., Feinstein A. R. Alternative analytic methods for case control studies of estrogens and endometrial cancer. N Engl J Med 1978; 299: 1089
- Lauritzen C. Oestrogens and endometrial cancer: A point of view. Clin Obstet Gynaecol 1977; 4: 145
- Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976; 294: 1262
- McDonald T. W., Annegers J. F., O'Fallon W. M., Dockerty M. B., Malkasian G. D., Kurlan L. T. Exogenous estrogen and endometrial carcinoma: Case-control and incidence study. Am J Obstet Gynecol 1977; 127: 572
- Meema H. E., Meema S. Prevention of postmeno-pausal osteoporosis by hormone treatment of the menopause. Can Med Assoc J 1968; 99: 248
- Persson I., Adami H.-O., Lindberg B. S., Johansson E. D. B., Manell P. Practice and patterns of estrogen treatment in climacteric women in a Swedish population. A descriptive epidemiological study. Part I. Acta Obstet Gynecol Scand 1983; 62: 289
- Punnonen R. Effect of castration and peroral estrogen therapy on the skin. Acta Obstet Gynecol Scand (Suppl.) 1972; 21
- Rauramo L. Choice of estrogen and mode of administration in menopausal therapy. International Congress Series No. 512 Gynecology and Obstetrics. Proceedings of the IX World Congress of Gynecology and Obstetrics, Tokyo, October, 25–311971, Editors: Shoichi Sakamoto, Shimpei Tojo and Tetsuya Nakayama. Ex-cerpta Medica, Amsterdam-Oxford-Princeton. ISBN Excerpta Medica 90 219 0440 3, ISBN Elsevier North-Holland 0 444 90139 6
- Riggs B. L., Jowsey J., Kelly P. J., Jones J. D., Maher F. T. Effect of sex hormones on bone in primary osteoporosis. J Clin Invest 1969; 48: 1065
- Salmi T. Risk Factors in Endometrial Carcinoma with Special Reference to the Use of Estrogens. Turku 1979
- Smith D. C., Prentice R., Thompson D. J., Herrmann W. L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975; 293: 1164
- Studd J. W. W., Schleyer-Saunders E. Oestrogens as a cause of endometrial carcinoma. Br Med J 1976; i: VI144
- Wigle D. T., Grace M., Smith E. S. D. Estrogen use and cancer of the uterine corpus in Alberta. Can Med Assoc J 1978; 118: 1276
- Völker W., Kannenglesser U., Majewski A., Vsterling H. W. Östrogentherapie und Endometriumkarzi-nom. Geburtsh Frauenheilk 1978; 38: 735
- Young M. M., Jasani C, Smith D. A., Nordin B. E.C. Some effects of ethinyl oestradiol on calcium and phosphorus metabolism in osteoporosis. Clin Sci 1968; 34: 411
- Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975; 293: 1167